Roitt I, Brostoff J, Male D. Immunology. 1996:420.

Souba WW. Cytokine control of nutrition and metabolism during critical illness. Curr Probl Surg. 1994;31:577-643.

Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth. 1997;78:201-219.

Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg. 1993;80:289-297.

Hesse D, Davatelis G, Felsen D. Cachectin/tumor necrosis factor gene expression in Kupffer cells. J Leuk Biol. 1987;42:422.

Beutler B, Cerami A. The common mediator of shock, cachexia, and tumor necrosis. Adv Immunol. 1988;42:213-231.

Beutler B, Krochin N, Milsark IW. Control of cachectin (Tumor Necrosis Factor) synthesis: mechanisms of endototoxin resistance. Science. 1997;232:977-979.

Tsujimoto M, Vilcek J. Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-g. J Biol Chem. 1986;261:5384-5388.

Waage A, Brandtzaeg P, Halstensen A. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med. 1989;169:333-338.

Fong Y, Moldawer LL, Shires T. The biological characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet. 1990;170:363-378.

Dinarello CA, Cannon JG, Wolff SM. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986;163:1433-1450.

Stern DM, Nawroth PP. Modulation of endothelial hemostatic properties by tumour necrosis factor. J Exp Med. 1986;163:740-745.

Dinarello CA. Biology of interleukin 1. FASEB Journal. 1988;2:108-115.

May LT, Ghrayeb J, Santhanam U. Synthesis and secretion of multiple forms of b2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocyts. J Biol Chem. 1989;263:7760-7766.

Mcbride WT, Armstrong MA, Crockard AD. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth. 1995;75:724-733.

Gilliland HE, Armstrong MA, Carabine U. The choice of anesthetic maintenance technique influences the anti-inflammatory cytokine response to abdominal surgery. Anesth Analg. 1997;85:1394-1398.

Miller LC, Dinarello CA. Biological activities of interleukin-1 relevant to rheumatic diseases. Pathol Immunopathol Res. 1987;6:22-36.

Girardin E, Grau GE, Dayer JM. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med. 1988;319:397-400.

Maury CPJ, Salo E, Pelkonen P. Circulating interleukin 1 beta in patients with Kawasaki disease. N Engl J Med. 1988;319:1670-1671.

Helle M, Brankenhoff JP, De Groot ER. Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol. 1988;18:957-959.

Kishimoto T. The biology of interleukin-6. Blood. 1989;74:1-10.

Paul WE, Laughlin CA, Johnston MI. Report of nomenclature discussion. Ann New York Acad Sci. 1898;557:579-580.

Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1-78.

Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 1989;61:588-602.

Berek JS, Chung C, Kaldi K. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1991;164:1038-1043.

Koo AS, Armstrong C, Bochner B. Interleukin-6 and renal cell cancer: production, regulation, and growth affects. Cancer Immunol Immunother. 1992;35:97-105.

Houssiau FA, Devogelaer JP, Van Damme J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988;31:784-788.

Waage A, Kaufmann C, Espevik T. Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol. 1989;50:394-398.

Sehgal PB, Walther Z, Tamm I. Rapid enhancement of b2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglicerols and the calcium ionophore A23187. Proc Natl Acad Sci. 1987;84:3663-3667.

Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon- b2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem. 1988;263:6177-6182.

Zhang Y, Lin JX, Yip YK. Enhancement of cAMP levels and protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci. 1988;85:6802-6805.

Shalaby MR, Waage A, Aarden L. Endotoxin, tumor necrosis factor-a and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol. 1989;53:488-498.

Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood. 1990;15:1305-1310.

Bertolucci M, Perego C, De Simoni MG. Interleukin-6 is differently modulated by central opioid receptor subtypes. Am J Physiol. 1997;273:R956-R959.

Taga T, Hibi M, Hirata Y. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989;58:573-581.

Hibi M, Murakami M, Saito M. Molecular cloning and expression of an IL-6 signal transducer gp130. Cell. 1990;63:1149-1157.

Nijsten MWN, De Groot ER, Ten Duis HJ. Serum levels of interleukin-6 and acute phase responses. Lancet. 1987;2:921.

Van Oers MHJ, Van Der Heyden AAPAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988;71:314-319.

Ertel W, Faist E, Nestle C. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res. 1990;48:622-628.

Castell JV, Gómez-Lechón MJ, David M. Acute-phase response of human hepatocyts: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12:1179-1186.

Bauman H, Gaudie J. The acute phase response. Immunol Today. 1994;15:74-80.

Hirano T, Akira S, Taga T. Biological and clinical aspects of interleukin-6. Immunol Today. 1990;11:443-449.

Borden EC, Chin P. Interleukin-6: A cytokine with potential diagnostic and therapeutic roles. J Lab Clin Med. 1994;123:824-829.

Stouthard JML, Romijn JA, Van der Poll T. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol. 1995;268:813-819.

Buelens C, Willens F, Delvaux A. Interleukin-10 differentially regulates B7-1(CD80) and B7-2(CD86) expression on human peripheral blood dendritic cells. Eur J Immunol. 1995;25:2668-2672.

Weissman C. The metabolic response to stress: an overview and update. Anesthesiology. 1990;73:308-327.

Epstein J, Breslow MJ. The stress response of critical illness. Crit Care Clin. 1999;15:17-33.

Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.

Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81-88.

Wortel CH, Van Deventer SJ, Aarden LA. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993;114:564-570.

Padova F, Pozzi C, Tondre MJ. Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol. 1991;85:137-142.

Kotani G, Usami M, Kasahara H. The relationship of IL-6 to hormonal mediators, fuel utilization, and systemic hypermetabolism after surgical trauma. Kobe J Med Sci. 1996;42:187-205.

Cruickshank AM, Fraser WD, Burns HJ. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci. 1990;79:161-165.

Joris J, Cigarini I, Legrand M. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth. 1992;69:341-345.

Hall GM, Desborough JP. Interleukin-6 and the metabolic response to surgery. Br J Anaesth. 1992;69:337-338.

Jakeways MSR, Mitchell V, Hashim IA. Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. Br J Surg. 1994;81:127-131.

Kawamura T, Wakusawa R, Okada K. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin-8 and 6 in reperfusion injury. Can J Anaesth. 1993;40:1016-1021.

Hill GE. Cardiopulmonary bypass-induced inflammation: is it important?. J Cardiothorac Vasc Anesth. 1998;12:21-25.

Whitten CW, Hill GE, Ivy R. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and / or blood product administration, influence the IL-6 response to cardiac surgery?. Anesth Analg. 1998;86:28-33.

Brix-Christensen V, Tonnesen E, Sorensen IJ. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery. Acta Anaesthesiol Scand. 1998;42:63-70.

Avall A, Hyllner M, Bengtson JP. Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology. 1997;87:511-516.

Ashcroft GS, Masterson GR. Interleukin-6 and wound healing. Br J Anaesth. 1994;73:426.

Ueo H, Inoue H, Honda M. Production of interleukin-6 at operative wound sites in surgical patients. J Am Coll Surg. 1994;179:326-332.

Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth. 1996;77:110-117.

Gardlund B, Sjolin J, Nilsson A. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infec Dis. 1995;172:296-301.

Damas P, Ledoux D, Nys M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356-362.

Chollet-Martin S, Montravers P, Gibert C. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun. 1993;61:4553-4559.

Hack CE, Hart M, Van Schijndel RJMS. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infection and Immunity. 1992;60:2835-2842.

Suffredini AF. Currents prospects for the treatment of clinical sepsis. Crit Care Med. 1994;22:S12-S18.

Dray A. Inflammatory mediators of pain. Br J Anaesth. 1995;75:125-131.

Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63:289-302.

Cunha FQ, Poole S, Lorenzetti BB. The pivotal role of tumour necrosis factor a in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107:660-664.

Watkins LR, Wiertelak EP, Goehler LE. Characterization of cytokine-induced hyperalgesia. Brain Res. 1994;654:15-26.

Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 1995;57:1011-1026.

Chang DM, Baptiste P, Schur PH. The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol. 1990;17:1148-1157.

Meddings JB, Hogaboam CM, Tran K. Capsaicin effects on non-neural plasma membranes. Biochim Biophys Acta. 1991;1070:43-50.

Ferreira SH. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993;46:1-9.

Stefano GB, Kushnerik V, Rodriguez M. Inhibitory effect of morphine on granulocyte stimulation by tumor necrosis factor and substance P. Int J Immunopharmacol. 1994;16:329-334.

Rang HP, Urban L. New molecules in analgesia. Br J Anaesth. 1995;75:145-156.

Lee JC, Badger AM, Griswold DE. Bicyclic imidazolines as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci. 1993;696:149-170.

Naito Y, Tamai S, Shingu K. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology. 1992;77:426-431.

Schulze S, Sommer P, Bigler D. Effect of combined prednisolone, epidural analgesia, and indomethacin on the systemic response after colonic surgery. Arch Surg. 1992;127:325-331.

Norman JG, Fink GW. The effects of epidural anesthesia on the neuroendocrine response to major surgical stress: a randomized prospective trial. Am Surg. 1997;63:75-80.

Moore CM, Desborough JP, Powell H. Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery. Br J Anaesth. 1994;72:272-279.

De Jongh RF, Bosmans EP, Puylaert MJ. The influence of anaesthetic techniques and type of delivery on peripartum serum interleukin-6 concentrations. Acta Anaesthesiol Scand. 1997;41:853-860.

Crozier TA, Müller JE, Quittkat D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth. 1994;72:280-285.

Taylor NM, Lacoumenta S, Hall GM. Fentanyl and interleukin-6 response to surgery. Anaesthesia. 1997;52:112-115.

Roytblat L, Talmor D, Rachinsky M. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg. 1998;87:266-271.

Jameson P, Desborough JP, Bryant AE. The effect of cortisol suppression on interleukin-6 and white blood cell responses to surgery. Acta Anaesthesiol Scand. 1997;41:304-308.

Eriksson-Mjoberg M, Kristiansson M, Carlstrom K. Preoperative infiltration of bupivacaine: effects on pain relief and trauma response (cortisol and interleukin-6). Acta Anaesthesiol Scand. 1997;41:466-472.